Drug-induced aseptic meningitis

Bibliography

• DAVISON SP, MARION MS: Sensorineural hearing loss caused by NSAID-induced aseptic meningitis. Ear Nose Throat (1998) 77:820–826.
   PubMedGoogle Scholar
• AGUS B, NELSON J, KRAMER N, MAHAL SS, ROSENSTEIN ED: Acute central nervous system symptoms caused by ibuprofen in connective tissue disease. Rheumatol. (1990) 17:1094–1096.
   Web of Science ®Google Scholar
• JENSEN S, GLUD TK, BACHER T, ERSGAARD H: Ibuprofen-induced meningitis in a male with systemic lupus erythematosus. Acta Med. Scand. (1987) 221:509–511.
   PubMed Web of Science ®Google Scholar
• HARRISON MS, SIMONTE SJ, KAUFFMAN CA: Trimethoprim-induced aseptic meningitis in a patient with AIDS: case report and review. Clin. Infect. Dis. (1994) 19:431–434.
   PubMed Web of Science ®Google Scholar
• DAVIS BJ, THOMPSON J, PEIMANN A, BENDIXEN BH: Drug-induced aseptic meningitis caused by two medications. Neurology (1994) 44:984–985
   PubMed Web of Science ®Google Scholar
• DERBES SJ: Trimethoprim-induced aseptic meningitis. "AMA (1984) 252:2865–2866
   PubMed Web of Science ®Google Scholar
• HEDLUND J, AURELIUS E, ANDERSSON J: Recurrent encephalitis due to trimethoprim intake. Scand. Infect. Dis. (1990) 22:109–112.]
   Google Scholar
• BLUMENFELD H, CHA JH, CUDKOWICZ ME: Trimethoprim and sulfonamide-associated meningoencephalitis with MRI correlates. Neurology (1996) 46:556–558
   PubMed Web of Science ®Google Scholar
• CAP ONE PM, COHEN ME: Seizures and cerebritis associated with administration of OKT 3. Pediatr. Neurol (1991) 7:299–301
   PubMed Web of Science ®Google Scholar
• EUSTACE S, BUFF B: Magnetic resonance imaging in drug-induced meningitis. Can. Assoc. Radial. J. (1994) 45:463–465
   PubMed Web of Science ®Google Scholar
• OBERMOSER G, BELLMANN R, PFAUSLER B, SCHMUTZHARD E, SEPP N: Aseptic meningo-encephalitis related to dexibuprofen use in a patient with systemic lupus erythematosus: a case report with MR findings. Lupus (2002) 11:451–453
   PubMed Web of Science ®Google Scholar
• CAPRA C, MONZA GM, MEAZZA G, RAMELLA G: Trimethoprim-sulfamethoxazole-induced aseptic meningitis: case report and literature review. Intensive Care Med. (2000) 26:212–214
   PubMed Web of Science ®Google Scholar
• GARAGUSI VF, NEEFE LI, MANN 0: Acute meningoencephalitis: Association with isoniazid administration. JAMA (1976) 235:1141–1142
   PubMed Web of Science ®Google Scholar
• LORTHOLARY A, VARACHE N, BOUACHOUR G, SZAPIRO N, BOURRIER P, ALQUIER P: Generalized status epilepticus after ingestion of ibuprofen (BrufeM, disclosing systemic lupus erythematosus. Rev Med. Interne (1990) 11:243–244
   PubMed Web of Science ®Google Scholar
• PATEY 0, LACHEHEB A, DELLION S, ZANDITENAS D, JUNGFER-BOUVIER F, LAFAIX C: A rare case of cotrimoxazole-induced eosinophilic aseptic meningitis in an HIV-infected patient. Scand. J. Infect. Dis. (1998) 30:530–531
   PubMed Web of Science ®Google Scholar
• PERERA DR, SEIFFERT AK, GREELEY HM: Ibuprofen and meningoencephalitis. Ann. Intern. Med. (1984) 100:619
   PubMed Web of Science ®Google Scholar
• MALLAT Z, VASSAL T, NAOURI JF, PRIER A, LAREDO JD, OFFENSTADT G: Aseptic meningoencephalitis after iopamidol myelography. Lancet (1991) 338:252
   PubMed Web of Science ®Google Scholar
• JOLLES S, SEWELL WA, LEIGHTON C: Drug-induced aseptic meningitis: diagnosis and management. Drug Sal (2000) 22:215–226
   PubMed Web of Science ®Google Scholar
• BROUNS R, CROLS R, ENGELBORGHS S, DE DEYN PP: Pituitary apoplexy presenting as chemical meningitis. Lancet (2004) 364:502
   PubMed Web of Science ®Google Scholar
• CARMEL PW, GREIF LK: The aseptic meningitis syndrome: a complication of posterior fossa surgery. Pediatr. Neurosurg. (1993) 19:276–280
   PubMed Web of Science ®Google Scholar
• BENNETT RA, HARBILAS E: Wilson's disease with aseptic meningitis and penicillamine-related cheilosis. Arch. Intern. Med. (1967) 120:374–376
   PubMed Web of Science ®Google Scholar
• AUSTIN DA, SOKOLOWSKI JW, JR: Postlumbar puncture chemical meningitis. N Y State J. Med. (1968) 68:2444–2446
   PubMedGoogle Scholar
• ENG RH, SELIGMAN SJ: Lumbar puncture-induced meningitis. JAMA (1981) 245:1456–1459
   PubMed Web of Science ®Google Scholar
• NO AUTHORS LISTED: Principles and Practice of Infectious Diseases: Churchill Livingstone, 2000
   Google Scholar
• HOFFMAN M, GRAY RG: Ibuprofen-induced meningitis in mixed connective tissue disease. Clin. Rheumatol (1982) 1:128–130
   PubMed Web of Science ®Google Scholar
• BALLAS ZK, DONTA ST: Sulindac-induced aseptic meningitis. Arch. Intern. Med. (1982) 142:165–166
   PubMed Web of Science ®Google Scholar
• RUPPERT GB, BARTH WF: Tolmetin-induced aseptic meningitis. JAMA (1981) 245:67–68
   PubMed Web of Science ®Google Scholar
• RIVER Y, AVERBUCH-HELLER L, WEINBERGER M et al.: Antibiotic induced meningitis. I Neurol Neurosurg. Psychiatry (1994) 57:705–708
   PubMed Web of Science ®Google Scholar
• MORIS G, GARCIA-MONCO JC: The challenge of drug-induced aseptic meningitis. Arch. Intern. Med. (1999) 159:1185–1194.
   PubMed Web of Science ®Google Scholar
• ••This paper presents a detailed review ofpatent characteristics with DIAM
   Google Scholar
• SEKUL EA, CUPLER EJ, DALAKAS MC: Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann. Intern. Med. (1994) 121:259–262
   PubMed Web of Science ®Google Scholar
• WIDENER HL, LITTMAN BH: Ibuprofen-induced meningitis in systemic lupus erythematosus. JAMA (1978) 239:1062–1064
   PubMed Web of Science ®Google Scholar
• ASHWATH ML, KATNER HP: Recurrent aseptic meningitis due to different non-steroidal anti-inflammatory drugs including rofecoxib. Postgrad. Med. J. (2003) 79:295–296
   PubMed Web of Science ®Google Scholar
• NGUYEN HT, JUURLINK DN: Recurrent ibuprofen-induced aseptic meningitis. Ann. Pharmacother. (2004) 38:408–410
   PubMed Web of Science ®Google Scholar
• BONNEL RA, VILLALBA ML, KARWOSKI CB, BEITZ J: Aseptic meningitis associated with rofecoxib. Arch. Intern. Med. (2002) 162:713–715
   PubMed Web of Science ®Google Scholar
• PISANI E, FATTORELLO C, LEOTTA MR, MARCELLO 0, ZULIANI C: Recurrence of ibuprofen-induced aseptic meningitis in an otherwise healthy patient. Ital. J. Neurol Sci. (1999) 20:59–62
   PubMedGoogle Scholar
• SEATON RA, FRANCE AJ: Recurrent aseptic meningitis following non- steroidal anti-inflammatory drugs-a reminder. Postgrad. Med. J. (1999) 75:771–772
   PubMed Web of Science ®Google Scholar
• WEKSLER BB, LEHANY AM: Naproxen-induced recurrent aseptic meningitis. DICP (1991) 25:1183–1184
   PubMedGoogle Scholar
• MIFSUD AJ: Drug-related recurrent meningitis. J. Infect. (1988) 17:151–153
   PubMed Web of Science ®Google Scholar
• VON REYN CF: Recurrent aseptic meningitis due to sulindac. Ann. Intern. Med. (1983) 99:343–344
   PubMed Web of Science ®Google Scholar
• TREVES R, GASTINE H, RICHARD A et al.: Aseptic meningitis and acute renal failure induced by ibuprofen during the treatment of systemic lupus erythematosus. Rev Rhum. Mal. Osteoartic. (1983) 50:75–76
   PubMedGoogle Scholar
• SAMUELSON CO JR, WILLIAMS HJ: Ibuprofen-associated aseptic meningitis in systemic lupus erythematosus. West J. Med. (1979) 131:57–59
   PubMedGoogle Scholar
• WASNER CK: Ibuprofen, meningitis, andsystemic lupus erythematosus. ./. Rheumatol (1978) 5:162–164
   PubMed Web of Science ®Google Scholar
• CHEZ M, SILA CA, RANSOHOFF RM, LONGWORTH DL, WEIDA C: Ibuprofen-induced meningitis: detection of intrathecal IgG synthesis and immune complexes. Neurology (1989) 39:1578–1580
   PubMed Web of Science ®Google Scholar
• EWERT BH: Ibuprofen-associated meningitis in a woman with only serologic evidence of a rheumatologic disorder. Am. J. Med. Sci (1989) 297:326–327
   PubMed Web of Science ®Google Scholar
• GREENBERG GN: Recurrent sulindac-induced aseptic meningitis in a patient tolerant to other nonsteroidal anti-inflammatory drugs. South. Med. (1988) 81:1463–1464
   Google Scholar
• DURBACK MA, FREEMAN J, SCHUMACHER VR, JR: Recurrent ibuprofen-induced aseptic meningitis: third episode after only 200 mg of generic ibuprofen. Arthritis Rheum. (1988) 31:813–815
   PubMed Web of Science ®Google Scholar
• BOULAND DL, SPECHT NL, HEGSTAD DR: Ibuprofen and aseptic meningitis. Ann. Intern. Med. (1986) 104:731
   PubMed Web of Science ®Google Scholar
• FINCH WR, STROTTMAN MP: Acute adverse reactions to ibuprofen in systemic lupus erythematosus. JAMA (1979) 241:2616–2618
   PubMed Web of Science ®Google Scholar
• SONNENBLICK M, ABRAHAM AS: Ibuprofen hypersensitivity in systemic lupus erythematosus. Br. Med. J. (1978) 1:619–620
   PubMed Web of Science ®Google Scholar
• LORINO GD, HARDIN JG, JR: Sulindac-induced meningitis in mixed connective tissue disease. South. Med. J. (1983) 76:1185–1187
   PubMed Web of Science ®Google Scholar
• VAN DER ZWAN A, VAN DEM JG: Ibuprofen meningitis. Ned. Thdschr. Ceneeskd (1992) 136:1613–1614
   PubMedGoogle Scholar
• CODDING C, TARGOFF IN, MCCARTY GA: Aseptic meningitis in association with diclofenac treatment in a patient with systemic lupus erythematosus. Arthritis Rheum. (1991) 34:1340–1341
   PubMed Web of Science ®Google Scholar
• BERLINER S, WEINBERGER A, SHOENFELD Y et al.: Ibuprofen may induce meningitis in (NZB X NZW)F1 mice. Arthritis Rheum. (1985) 28:104–107.
   PubMed Web of Science ®Google Scholar
• ••This paper presents interesting data on theInduction of meningitis with ibuprofen in an SLE mouse model
   Google Scholar
• SHOENFELD Y, LIVNI E, SHAKLAI M, PINKHAS J: Sensitization to ibuprofen in systemic lupus erythematosus. IA/VIA (1980) 244:547–548
   Web of Science ®Google Scholar
• BARRETT P, THIER S: Meningitis and pancreatitis associated with sulfamethizole. N Engl. J. Med. (1963) 268:36–37.
   PubMed Web of Science ®Google Scholar
• •This is the first paper describing antibiotic-induced aseptic meningitis
   Google Scholar
• THAUNAT 0, GILQUIN J, LAZARETH I, PRIOLLET P: Amoxicillin-induced aseptic meningo-encephalitis. Allergy (2003) 58:687–688
   PubMed Web of Science ®Google Scholar
• KASTENBAUER S, PFISTER HW, WICK M: No evidence of Type 1 or Type 3 hypersensitivity mechanism in amoxicillini clavulanic acid induced aseptic meningitis. Neurol Neurosurg. Psychiatry (2003) 74:690–691
   PubMed Web of Science ®Google Scholar
• FARMER L, ECHLIN FA, LOUGHLIN WC, BREAKEY AS, DUVOISIN R: Pachymeningitis apparently due to penicillin hypersensitivity. Ann. Intern. Med. (1960) 52:910–914
   PubMed Web of Science ®Google Scholar
• WITTMANN A, WOOTEN GF: Amoxicillin-induced aseptic meningitis. Neurology (2001) 57:1734
   PubMed Web of Science ®Google Scholar
• CZERWENKA W, GRUENWALD C, CONEN D: Aseptic meningitis after treatment with amoxicillin. BL Med. (1999) 318:1521
   PubMed Web of Science ®Google Scholar
• JACOBSSON G, ELOWSON S: Amoxicillin caused aseptic meningoencephalitis. Lakartidningen (1999) 96:201–202
   PubMedGoogle Scholar
• MATEOS V, CALLEJA S, JIMENEZ L, SUAREZ-MORO R: Recurrent aseptic meningitis associated with amoxicillin-clavulanic acid. Med. Clin. (Bart) (2000) 114:79
   PubMed Web of Science ®Google Scholar
• EHSAN T, MALKOFF MD: Acute isoniazid poisoning simulating meningoencephalitis. Neurology (1995) 45:1627–1628
   PubMed Web of Science ®Google Scholar
• FOBELO MJ, CORZO DELGADO JE, ROMERO AA, GOMEZ-BELLVER MJ: Aseptic meningitis related to valacyclovir. Ann. Pharmacother. (2001) 35:128–129
   PubMed Web of Science ®Google Scholar
• OLIN JL, GUGLIOTTA JL: Possible valacyclovir-related neurotoxicity and aseptic meningitis. Ann. Pharmacother. (2003) 37:1814–1817
   PubMed Web of Science ®Google Scholar
• KISHIYAMA JL, VALACER D, CUNNINGHAM-RUNDLES C et al: A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. Clin. Immunol (1999) 91:126–133.
   PubMed Web of Science ®Google Scholar
• ••This is a randomised control trial wghichdemonstrates increased probable and definite cases of DIAM secondary to IVIg compared to placebo (albumin)
   Google Scholar
• SCHIAVOTTO C, RUGGERI M, RODEGHIERO F: Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. Haematologica (1993) 78:35–40
   PubMedGoogle Scholar
• OZSOYLU S: Aseptic meningitis and intravenous gammaglobulin treatment. Am. J. Dis. CA/M(1993) 147:129–130
   PubMedGoogle Scholar
• MSELATI JC, CARLIER JC, ROUTON MC, NOUI MF, DE GENNES C: [Intravenous immunoglobulins and aseptic meningitis]. Arch. Fr. Pediatr. (1992) 49:216
   PubMedGoogle Scholar
• OBANDO I, DURAN I, MARTIN-ROSA L, CANO JM, GARCIA-MARTIN FJ: Aseptic meningitis due to administration of intravenous immunoglobulin with an unusually high number of leukocytes in cerebrospinal fluid. Pediatr. Emerg. Care (2002) 18:429–432
   PubMed Web of Science ®Google Scholar
• KATO T, SUZUKI E, SONE M, YOSHIDA E, HIRAYAMA M: A case of recurrent aseptic meningitis caused by high-dose intravenous gammaglobulin therapy for chronic inflammatory demyelinating polyneuropathy. Rinsho Shinkeigaku (2001) 41:797–800
   PubMedGoogle Scholar
• JOLLES S, HILL H: Management of aseptic meningitis secondary to intravenous immunoglobulin. BE Med. J. (1998) 316:936
   PubMed Web of Science ®Google Scholar
• LAFFERTY TE, DEHORATIUS RJ, SMITH JB: Aseptic meningitis as a side effect of intravenous immune gammaglobulin. Rheumatol (1997) 24:2491–2492
   Web of Science ®Google Scholar
• PICTON P, CHISHOLM M: Aseptic meningitis associated with high dose immunoglobulin: case report. BE Med. J. (1997) 315:1203–1204
   PubMed Web of Science ®Google Scholar
• PREMINGER-SHAPIRO R, NUSSINOVITCH M, SOEN G, VARSANO I: Aseptic meningitis: a frequent side-effect of intravenous immunoglobulin? Eur. j Pediatr. (1995) 154:866–867
   Web of Science ®Google Scholar
• ELLIS RJ, SWENDSON MR, BAJOREK J: Aseptic meningitis as a complication of intravenous immunoglobulin therapy for myasthenia gravis. Muscle Nerve (1994) 17:683–684
   PubMed Web of Science ®Google Scholar
• DE VLIEGHERE FC, PEETERMANS WE, VERMYLEN J: Aseptic granulocytic meningitis following treatment with intravenous immunoglobulin. Infect. Dis. (1994) 18:1008–1010
   Google Scholar
• MISBAH SA, CHAPEL HM: Adverse effects of intravenous immunoglobulin. Drug Sal (1993) 9:254–262
   PubMed Web of Science ®Google Scholar
• MITTERER M, PESCOSTA N, VOGETSEDER W, MAIR M, COSER P: Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura. Ann. Hematol (1993) 67:151–152
   PubMed Web of Science ®Google Scholar
• CASTEELS-VAN DAELE M, WIJNDAELE L, BROCK P, KRUGER M, GILLIS P: Aseptic meningitis associated with high dose intravenous immunoglobulin therapy. I Neurol. Neurosurg. Psychiatry (1992) 55:980–981
   PubMed Web of Science ®Google Scholar
• MOLINA JM, COFFINEAU A, RAIN JD, LETONTURIER D, MODAI J: Aseptic meningitis following administration of intravenous immune globulin. Clin. Infect. Dis. (1992) 15:564–565
   PubMed Web of Science ®Google Scholar
• VERA-RAMIREZ M, CHARLET M, PARRY GJ: Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. Neurology (1992) 42:1636–1637
   PubMed Web of Science ®Google Scholar
• PALLARES DE, MARSHALL GS: Acute aseptic meningitis associated with administration of intravenous immune globulin. An 7 Pediatr. Hematol Oncol. (1992) 14:279
   PubMed Web of Science ®Google Scholar
• RAO SP, TEITLEBAUM J, MILLER ST: Intravenous immune globulin and aseptic meningitis. Am. J. Dis. Child (1992) 146:539–540
   PubMedGoogle Scholar
• WATSON JD, GIBSON J, JOSHUA DE, KRONENBERG H: Aseptic meningitis associated with high dose intravenous immunoglobulin therapy. I Neurol. Neurosurg. Psychiatry (1991) 54:275–276
   PubMed Web of Science ®Google Scholar
• CASTEELS-VAN DAELE M, WIJNDAELE L, HANNINCK K, GILLIS P: Intravenous immune globulin and acute aseptic meningitis. N Engl. J. Med. (1990) 323:614–615
   PubMed Web of Science ®Google Scholar
• KRESSEBUCH H, SCHAAD UB, HIRT A, BIANCHETTI MG: Cerebrospinal fluid inflammation induced by intravenous immunoglobulins. Pediam Infect. Dis. J. (1992) 11:894–895
   PubMed Web of Science ®Google Scholar
• KATTAMIS AC, SHANKAR S, COHEN AR: Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G. .1 Pediatr. (1997) 130:281–283
   Web of Science ®Google Scholar
• MEINER Z, BEN HURT, RIVER Y, RECHES A: Aseptic meningitis as complication of intravenous immunoglobulin therapy for myasthenia gravis. I Neurol Neurosurg. Psychiatry (1993) 56:830–831
   PubMed Web of Science ®Google Scholar
• NEWLAND AC, BURTON I, CAVENAGH JD ET AL.: Vigam-S, a solvent/detergent-treated intravenous immunoglobulin, in idiopathic thrombocytopenic purpura. Transfus. Med. (2001) 11:37–44
   Google Scholar
• BALFOUR-LYNN IM, MOHAN U, BUSH A, ROSENTHAL M: Intravenous immunoglobulin for cystic fibrosis lung disease: a case series of 16 children. Arch. Dis. Child. (2004) 89:315–319
   PubMed Web of Science ®Google Scholar
• SHORR AF, KESTER KE: Meningitis and hepatitis complicating intravenous immunoglobulin therapy. Ann. Pharmacother. (1996) 30:1115–1116
   PubMed Web of Science ®Google Scholar
• YAMAZAKI M, MIZUTANI T, KATO M et al: Aseptic meningitis induced by high-dose gamma-globulin in an adult woman with antiphospholipid syndrome and chronic idiopathic thrombocytopenic purpura. Rinsho Ketsueki (1999) 40:1110–1115
   PubMedGoogle Scholar
• EMMONS C, SMITH J, FLANIGAN M: Cerebrospinal fluid inflammation during OKT3 therapy. Lancet (1986) 2:510–511
   PubMed Web of Science ®Google Scholar
• RODEN J, KLINTMALM GB, HUSBERG BS, NERY J, OLSON LM: Cerebrospinal fluid inflammation during OKT3 therapy. Lancet (1987) 2:272
   PubMed Web of Science ®Google Scholar
• JOY ME, MICHALS ML, CANAFAX DM: Aseptic meningitis associated with muromonab-CD3 therapy. Clin. Pharm. (1988) 7:721
   PubMedGoogle Scholar
• MARTIN MA, MASSANARI RIVI, NGHIEM DD, SMITH JL, CORRY RJ: Nosocomial aseptic meningitis associated with administration of OKT3.JAMA (1988) 259: 2002-2005
   Google Scholar
• THISTLETHWAITE JR, STUART JK, MAYES JT et al: Complications and monitoring of OKT3 therapy. Am. Kidney Dis. (1988) 11:112–119
   PubMed Web of Science ®Google Scholar
• PAAP CM: Comment: muromonab CD3 aseptic meningitis. DICP (1989) 23:716–717
   PubMedGoogle Scholar
• SUTTON JD, PRIOLEAU MH, WORDELL CJ, FRANCOS GC: Aseptic meningitis associated with muromonab CD3 administration. DICP (1989) 23:257–258
   PubMedGoogle Scholar
• RELLO J, VALLVERDU I, COLL P, GURGUI M, NET A: Aseptic meningitis associated with muromonab-CD3.DICP (1990) 24:1233
   PubMedGoogle Scholar
• ADAIR JC, WOODLEY SL, O'CONNELL JB, CALL GK, BARINGER JR: Aseptic meningitis following cardiac transplantation: clinical characteristics and relationship to immunosuppressive regimen. Neurology (1991) 41:249–252
   PubMed Web of Science ®Google Scholar
• DREES C, HALEY CJ: Aseptic meningitis and muromonab-CD3 therapy. DICP (1991) 25:138–139
   PubMedGoogle Scholar
• URIBE ROCA MC, ZURRU MC, GATTO EM, MAGGIORA EC, AGOST CC, LUCIANO M: Aseptic meningitis due to OKT3.Neurologia (1998) 13:98–99
   PubMedGoogle Scholar
• THOMAS MC, WALKER R, WRIGHT A: HaNDL syndrome after 'benign' OKT3-induced meningitis. Transplantation (1999) 67:1384–1385
   PubMed Web of Science ®Google Scholar
• FIGG WD: Aseptic meningitis associated with muromonab-CD3.DICP (1991) 25:1395
   PubMedGoogle Scholar
• SERGENT JS, LOCKSHIN MD, KLEMPNER MS, LIPSKY BA: Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis. Am. I Med. (1975) 58:644–654
   PubMed Web of Science ®Google Scholar
• MERRIN P, WILLIAMS IA: Meningitis associated with sulphasalazine in a patient with Sjogren's syndrome and polyarthritis. Ann. Rheum. Dis. (1991) 50:645–646
   PubMed Web of Science ®Google Scholar
• COHEN JD, JORGENSEN C, SANY J: Leflunomide-induced aseptic meningitis. Joint Bone Spine (2004) 71:243–245.
   PubMed Web of Science ®Google Scholar
• •This is a relatively new agent and the first described case of DIAM
   Google Scholar
• MAROTTE H, CHARRIN JE, MIOSSEC P: Infliximab-induced aseptic meningitis. Lancet (2001) 358:1784.
   PubMed Web of Science ®Google Scholar
• •This is a new anti-TNF-a monoclonal antibody which has caused a DIAM
   Google Scholar
• MILLER E, GOLDACRE M, PUGH S et al.: Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children. Lancet (1993) 341:979–982.
   PubMed Web of Science ®Google Scholar
• ••This paper describes the ascertainment ofincreased cases of aseptic meningitis with the Urabe vaccine strain based on Public Health Laboratory and hospital records in the UK
   Google Scholar
• DA CUNHA SS, RODRIGUES LC, BARRETO ML, DOURADO I: Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain. Vaccine (2002) 20:1106–1112
   PubMed Web of Science ®Google Scholar
• DA SILVEIRA CM, KMETZSCH CI, MOHRDIECK R, SPERB AF, PREVOTS DR: The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, 153.HERLIHY TE: Phenazopyridine and aseptic meningitis. Ann. Intern. Med. (1987) 106:172–173
   Google Scholar
• LAFAURIE M, DIXMIER A, MOLINA JM: Aseptic meningitis associated with intravenous administration of dexchlorpheniramine. Ann. Med. Interne (Paris) (2003) 154:179–180
   PubMedGoogle Scholar
• OKAZAKI H, HATAKEYAMA M, MORI M, MINATO N, SUMIYA M, KANO S: A case of mixed connective tissue disease exacerbated by griseofulvin complicating aseptic meningo-encephalitis and disseminated intravascular coagulation. Ryumachi (1990) 30:418–425
   PubMedGoogle Scholar
• THILMANN AF, MOBIUS E, THILMANN RR, TOPPER R: Recurrent aseptic meningitis (Mollaret meningitis)- spontaneous and drug-induced origin. Fortschr. Neurol Psychiatr. (1991) 59:493–497
   PubMed Web of Science ®Google Scholar
• JOFFE AM, FARLEY JD, LINDEN D, GOLDSAND G: Trimethoprim-sulfamethoxazole-associated aseptic meningitis: case reports and review of the literature. Am. J. Med. (1989) 87:332–338
   PubMed Web of Science ®Google Scholar
• JURADO R, CARPENTER SL, RIMLAND D: Case reports: trimethoprim-sulfamethoxazole-induced meningitis in patients with HIV infection. Am. I Med. Sci (1996) 312:27–29
   PubMed Web of Science ®Google Scholar
• CREEL GB, HURTT M: Cephalosporin-induced recurrent aseptic meningitis. Ann. Neurol (1995) 37:815–817.
   PubMed Web of Science ®Google Scholar
• •This paper demonstrates antigen-specific Immune responses in aseptic meningitis
   Google Scholar
• ANTONEN J, HULKKONEN J, PASTERNACK A, HURME M: Interleukin 6 may be an important mediator of trimethoprim-induced systemic adverse reaction resembling aseptic meningitis. Arch. Intern. Med. (2000) 160:2066-2067.•This demonstrates IL-6, IL-113 and TNF levels in a case of aseptic meningitis
   Google Scholar
• VAN GAMEREN MM, WILLEMSE PH, MULDER NH et al.: Effects of recombinant human interleukin-6 in cancer patients: a Phase I-II study. Blood (1994) 84:1434–1441
   PubMed Web of Science ®Google Scholar
• NARANJO CA, BUSTO U, SELLERS EM et al.: A method for estimating the probability of adverse drug reactions. Pharmacol Ther. (1981) 30:239–245.
   Web of Science ®Google Scholar
• ••This excellent paper provides a basis for classification of drug-induced adverse effects
   Google Scholar
• LEE RZ, HARDIMAN 0, O'CONNELL PG: Ibuprofen-induced aseptic meningoencephalitis. Rheumatology (Oxford) (2002) 41:353–355
   PubMed Web of Science ®Google Scholar
• HORN AC, JARRETT SW: Ibuprofen-induced aseptic meningitis in rheumatoid arthritis. Ann. Pharmacother. (1997) 31:1009–1011
   PubMed Web of Science ®Google Scholar
• COLAMARINO R, SOUBRIER M, ZENUT-LEAUD M, PRUDAT M, TOURNILHAC M, BUSSIERE JL: Aseptic meningitis caused by ibuprofen (Nurofen) in connective tissue diseases. Therapie (1993) 48:516–518
   PubMedGoogle Scholar
• GRIMM AM, WOLF JE: Aseptic meningitis associated with nonprescription ibuprofen use. DICP (1989) 23:712
   PubMedGoogle Scholar
• GILBERT GJ, EICHENBAUM HW: Ibuprofen-induced meningitis in an elderly patient with systemic lupus erythematosus. South. Med. J. (1989) 82:514–515
   PubMed Web of Science ®Google Scholar
• KATONA BG, WIGLEY FM, WALTERS JK, CASPI M: Aseptic meningitis from over-the-counter ibuprofen. Lancet (1988) 1:59
   PubMed Web of Science ®Google Scholar
• QUINN JP, WEINSTEIN RA, CAPLAN LR: Eosinophilic meningitis and ibuprofen therapy. Neurology (1984) 34:108–109
   PubMed Web of Science ®Google Scholar
• PECK MG, JOYNER PU: Ibuprofen-associated aseptic meningitis. Pharm. (1982) 1:561–565
   Google Scholar
• GIANSIRACUSA DF, BLUMBERG S, KANTROWITZ FG: Aseptic meningitis associated with ibuprofen. Arch. Intern. Med. (1980) 140:1553
   PubMed Web of Science ®Google Scholar
• HIDALGO NA, CARDENAS CR, NAJEM RN, CANTO DG: [Ibuprofen, aseptic meningitis, systemic lupus erythematosus]. Med. Clin. (Barc) (2004) 122:678–679
   Web of Science ®Google Scholar
• HANSON L: Ibuprofen-induced aseptic meningitis. I Tenn. Med. Assoc. (1994) 87:58
   PubMedGoogle Scholar
• KAPLAN BH, NEVITT MP, PACH JM, HERMAN DC: Aseptic meningitis and iridocyclitis related to ibuprofen. Am. Ophthalmol (1994) 117:119–120
   PubMed Web of Science ®Google Scholar
• MANDELL BF, RAPS EC: Severe systemic hypersensitivity reaction to ibuprofen occurring after prolonged therapy. Am. J. Med. (1987) 82:817–820
   PubMed Web of Science ®Google Scholar
• LAWSON JM, GRADY MJ: Ibuprofen-induced aseptic meningitis in a previously healthy patient. West J. Med. (1985) 143:386–387
   PubMedGoogle Scholar
• BERNSTEIN RF: Ibuprofen-related meningitis in mixed connective tissue disease. Ann. Intern. Med. (1980) 92:206–207
   PubMed Web of Science ®Google Scholar
• RUPPERT GB, BARTH WF: Ibuprofen hypersensitivity in systemic lupus erythematosus. South. Med.). (1981) 74:241–243
   PubMed Web of Science ®Google Scholar
• BAR-SELA S, LEVO Y, ZEEVI D, SLAVIN S, ELIAKIM M: A lupus-like syndrome due to Ibuprofen hypersensitivity. Rheumatol (1980) 7:379–380
   Web of Science ®Google Scholar
• LEE RP, KING EG, RUSSELL AS: Ibuprofen: a severe systemic reaction. Can. Med. Assoc. J. (1983) 129:854–855
   PubMed Web of Science ®Google Scholar
• PETERSON DI, BEN CHONG Y: Recurrent meningitis due to nonsteroidal anti-inflammatory drugs. Bull Clin. Neurosci. (1987) 52:40–42
   PubMedGoogle Scholar
• YASUDA Y, AKIGUCHI I, KAMEYAMA M: Sulindac-induced aseptic meningitis in mixed connective tissue disease. OM. Neurol Neurosurg. (1989) 91:257–260
   PubMed Web of Science ®Google Scholar
• NEUFELD MY, KORCZYN AD: Encephalopathy associated with sulindac. Hum. Toxicol (1986) 5:55
   PubMedGoogle Scholar
• SYLVIA LM, FORLENZA SW, BROCAVICH JM: Aseptic meningitis associated with naproxen. Drug Intel]. Clin. Pharm. (1988) 22:399–401
   PubMedGoogle Scholar
• CHAZAN B, WEISS A, WEINER Z, RIMBROT S, RAZ R: Drug induced aseptic meningitis due to diclofenac. Neurol (2003) 250:1503–1504
   Web of Science ®Google Scholar
• ROEL JE, GADANO AC, FALCON JL: Ketopraen and aseptic meningitis. Medicina (B Aires) (1991) 51:186
   PubMed Web of Science ®Google Scholar
• NAIR J, STACY M: Aseptic meningitis associated with salicylate overdose. Psychosomatics (1993) 34:372
   PubMed Web of Science ®Google Scholar
• PAPAIOANNIDES DH, KORANTZOPOULOS PG, GIOTIS CH: Aseptic meningitis possibly associated with celecoxib. Ann. Pharmacother. (2004) 38:172
   PubMed Web of Science ®Google Scholar
• REDMAN RC, MILLER JB, HOOD M, DEMAIO J: Trimethoprim-induced aseptic meningitis in an adolescent male. Pediatrics (2002) 110:e26
   PubMedGoogle Scholar
• GILROY N, GOTTLIEB T, SPRING P, PEIRIS 0: Trimethoprim-induced aseptic meningitis and uveitis. Lancet (1997) 350:112
   PubMed Web of Science ®Google Scholar
• DE LA MONTE SM, HUTCHINS GM, GUPTA PK: Aseptic meningitis, trimethoprim, and Sjogren's syndrome. JAMA (1985) 253:2192
   PubMed Web of Science ®Google Scholar
• SAHA H, LUMIO J, PASTERNACK A: Acute aseptic meningitis induced by trimethoprim. Duodecim (1988) 104:257–261
   PubMedGoogle Scholar
• MULLER MP, RICHARDSON DC, WALMSLEY SL: Trimethoprim-sulfamethoxazole induced aseptic meningitis in a renal transplant patient. Clin. Nephrol (2001) 55:80–84
   PubMed Web of Science ®Google Scholar
• MENG MV, ST LEZIN M: Trimethoprim-sulfamethoxazole induced recurrent aseptic meningitis. Um]. (2000) 164:1664–1665
   Web of Science ®Google Scholar
• TONOLLI I, VELUT JG, LAFAY V, THOMACHOT L, GAMBINI D, FRANCES Y: Cotrimoxazole-induced aseptic meningitis: two cases. Presse Med. (1998) 27:716–717
   PubMed Web of Science ®Google Scholar
• POLES L, THEODORE: Trimethoprim-sulphamethoxazole-induced meningitis. Harefuah (1996) 130:817-819, 879
   Google Scholar
• CARRILLO F, CUBERO A, HERNANDEZ GJ, JIMENEZ SP: Recurrence of meningoencephalitis induced by cotrimoxazole. Rev Neurol (1995) 23:142–144
   PubMedGoogle Scholar
• WONG JG, HATHAWAY SC, PAAT JJ, PATERSON RW, STEELE GH, JR: Drug-induced meningitis. A case involving trimethoprim-sulfamethoxazole. Postgrad. Med. (1994) 96:117–124
   Google Scholar
• ESCALANTE A, STIMMLER MM: Trimethoprim-sulfamethoxasole induced meningitis in systemic lupus erythematosus. Rheumatol (1992) 19:800-802.zoo. TUNKEL AR, STARR K: Trimethoprim-sulfamethoxazole-associated aseptic meningitis. Am. J. Med. (1990) 88:696–697
   Google Scholar
• GORDON ME ALLON M, COYLE PK: Drug-induced meningitis. Neurology (1990) 40:163-164.zoz. CARLSON J, WIHOLM BE: Trimethoprim associated aseptic meningitis. Scandj Infect. Dis. (1987) 19:687–691
   Google Scholar
• STREIFFER RH, HUDSON JG: Aseptic meningitis and trimethoprim-sulfamethoxazole. Fam. Pract. (1986) 23:314
   Web of Science ®Google Scholar
• KREMER I, RITZ R, BRUNNER F: Aseptic meningitis as an adverse effect of co-trimoxazole. N Engl. J. Med. (1983) 308:1481.zos. ANDRADE A, HILMAS E, WALTER C: A rare occurrence of trimethoprim! sulfamethoxazole (TMP/SMX)-induced aseptic meningitis in an older woman. J. Am. Ceriatr. Soc. (2000) 48:1537-1538 206.RUDY BJ, RUTSTEIN R: Aseptic meningitis from trimethoprim-sulfamethoxazole in an HIV-infected adolescent. Pediatr. Emerg. Care (1997) 13:216–217
   Google Scholar
• PASHANKAR D, MCARDLE M, ROBINSON A: Co-trimoxazole induced aseptic meningitis. Arch. Dis. Child (1995) 73:257–58
   PubMed Web of Science ®Google Scholar
• AUXIER GG: Aseptic meningitis associated with administration of trimethoprim and sulfamethoxazole. Am. J. Dis. Child (1990) 144:144-145.zos. BIOSCA M, DE LA FM, GARCIA-BRAGADO F, SAMPOL G: Aseptic meningitis due to trimethoprim-sulfamethoxazole. Neurol Neurosurg. Psychiatry (1986) 49:332–33
   Google Scholar
• HAAS EJ: Trimethoprim-sulfamethoxazole: another cause of recurrent meningitis. JAMA (1984) 252:346
   PubMed Web of Science ®Google Scholar
• THERRIEN R: Possible Trimethoprimi Sulfamethoxazole-Induced Aseptic Meningitis (November). Ann. Pharmacother. (2004) 212.CORSON AP, CHRETIEN JH: Metronidazole-associated aseptic meningitis. Clin. Infect. Dis. (1994) 19:974
   Google Scholar
• SUNDSTROM 0, SVEDBERG LE, CARLING L: Meningitis caused by metronidazole. Lakartidningen (1984) 81:3480
   PubMedGoogle Scholar
• ASPERILLA MO, SMEGO RA, JR: Eosinophilic meningitis associated with ciprofloxacin. Am. J. Med. (1989) 87:589–590
   PubMed Web of Science ®Google Scholar
• BODOKH I, LACOUR JP, COSTA I, BOTCAZOU V, CHICHMANIAN RIVI, ORTONNE JP: Aseptic meningitis during pyrazinamide therapy for lupus erythematosus. Presse Med. (1993) 22:595–596
   PubMed Web of Science ®Google Scholar
• MONDON M, OLLIVIER L, DAUMONT A: Aseptic meningitis ornidazole-induced in the course of infectious endocarditis. Rev Med. Interne (2002) 23:784–787.
   PubMed Web of Science ®Google Scholar